MicroRNA-7-regulated TLR9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway
about
MicroRNA-7: a promising new target in cancer therapyAntisense oligonucleotides against microRNA-21 reduced the proliferation and migration of human colon carcinoma cellsCanolol inhibits gastric tumors initiation and progression through COX-2/PGE2 pathway in K19-C2mE transgenic micemiR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcriptsComputational analysis of mRNA expression profiles identifies the ITG family and PIK3R3 as crucial genes for regulating triple negative breast cancer cell migrationDampening the signals transduced through hedgehog via microRNA miR-7 facilitates notch-induced tumourigenesis.Systems biology approach to stage-wise characterization of epigenetic genes in lung adenocarcinoma.The stimulatory activity of plasma in patients with advanced non-small cell lung cancer requires TLR-stimulating nucleic acid immunoglobulin complexes and discriminates responsiveness to chemotherapy.Host-virus interaction: the antiviral defense function of small interfering RNAs can be enhanced by host microRNA-7 in vitro.MicroRNA-7/NF-κB signaling regulatory feedback circuit regulates gastric carcinogenesis.Promoter mutation of tumor suppressor microRNA-7 is associated with poor prognosis of lung cancer.Hepatitis B Virus-Encoded X Protein Downregulates EGFR Expression via Inducing MicroRNA-7 in Hepatocellular Carcinoma CellsTLR9 expression is required for the development of cigarette smoke-induced emphysema in mice.Gram-negative bacteria facilitate tumor outgrowth and metastasis by promoting lipid synthesis in lung cancer patientsToll-like receptors in prostate infection and cancer between bench and bedsideMicroRNA-7 Deficiency Ameliorates the Pathologies of Acute Lung Injury through Elevating KLF4.TLR9 signaling repressed tumor suppressor miR-7 expression through up-regulation of HuR in human lung cancer cells.NLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-κB signaling.PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer.Role of 3'-untranslated region translational control in cancer development, diagnostics and treatment.miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways.Targeted Expression of miR-7 Operated by TTF-1 Promoter Inhibited the Growth of Human Lung Cancer through the NDUFA4 Pathway.MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.The role of microRNAs in lung cancer progression.Role of toll-like receptors in lung cancer.Novel inflammatory pathways in periodontitis.The molecular mechanisms and therapeutic potential of microRNA-7 in cancer.The Importance of Toll-like Receptors in NF-κB Signaling Pathway Activation by Helicobacter pylori Infection and the Regulators of this Response.miR-152 functions as a tumor suppressor in colorectal cancer by targeting PIK3R3.MiR-511 inhibits growth and metastasis of human hepatocellular carcinoma cells by targeting PIK3R3.MicroRNA-193a-3p and -5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.Relationship between miR-7 expression and treatment outcomes with gefitinib in non-small cell lung cancer.Quantitative assessment of short amplicons in FFPE-derived long-chain RNA.MicroRNA let-7f: a novel regulator of innate immune response in human endocervical cells.Roles of toll-like receptors: From inflammation to lung cancer progression.Toll-Like Receptor 9 Agonists for Cancer Therapy.Gram-negative bacteria facilitate tumor progression through TLR4/IL-33 pathway in patients with non-small-cell lung cancer.CiRS-7 targeting miR-7 modulates the progression of non-small cell lung cancer in a manner dependent on NF-κB signalling.Promoter-Operating Targeted Expression of Gene Therapy in Cancer: Current Stage and Prospect.Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer.
P2860
Q26777905-580BFEF9-B51A-4EB0-8EFD-3A820E72C65BQ28384798-FBB2A653-8EBA-4878-BA38-FA4CEE6BAF42Q28544414-B2D9C061-95C5-42CF-860B-9C5747E00630Q30540092-BE90DBA9-C838-43E2-9132-BFD6F6B20FB7Q33657062-0A3A3115-7483-41E3-A133-D7D5D77CBFC1Q34716485-DECE096E-E77D-48E4-9734-3512655A26B9Q35076075-9AEE4B1D-AF0E-4A86-899F-B57B498AF53DQ35189391-B3ABD353-F1A0-4F38-BAEF-7C7CE784E5A5Q35727756-C6C9E499-B7D2-4578-901F-636738903635Q35965465-E82646DF-C50B-4116-B078-CB9C97D7D159Q36336065-06CA0C0F-24D3-4204-B6C5-028CC1E793EEQ36956039-85670AA0-65C7-41D2-9355-16941E39B0A8Q37139546-34C5791D-F52F-40A1-AAF0-D912C4A9B133Q37208788-15A46F7B-4A8A-4E0F-9DFC-FB149A6F2DC1Q37295411-2BBA6AAF-44A9-49D7-A359-CB2AA1BA5FE5Q37318171-93D4FA60-F8B8-409F-A04C-FA72657E2209Q37357373-6880867E-2679-4F52-B2A9-3360538DB87CQ37362848-DADD9BFA-35A1-40DD-835F-4FE7F077EDCAQ37507398-682FCE5E-35F5-4D81-991A-5F9B65AD7E8BQ37617262-0B23574F-EE8B-425D-8A24-7A9539D8D34CQ37619788-DB4FFCAA-5C39-4479-A745-EBB61B4C32EDQ37718177-BB2008AD-58DC-4EE7-95AC-AD980E43893EQ37718382-2940CA30-CD25-4595-BB58-58DB100ECDCBQ38127375-B32C4D66-DA95-48EE-ABF9-96EA924243B9Q38196950-6DC9CC84-38A6-4B7E-891B-F203154F3E91Q38204890-4D850F51-D01B-4AC8-9981-9D5408CAFC03Q38272718-EE76D800-7571-4F04-A009-88A550366EA8Q38695809-16C2D2CA-51F6-484F-AAA2-E5C5F30EF910Q38798902-60F3527E-C5B8-4A2D-A507-86264EB40FB4Q38917852-76FDFCDB-534E-48F0-B324-9C275FBF243FQ39029964-BD0418BE-D9F3-46B3-942D-F69731137858Q41417865-8468D355-43D2-484D-AEF9-3AF2F31C18AFQ42292545-6C7D6575-AE6F-4BC1-A992-AFCE4891CFDBQ46718259-AC3306C2-F4C4-4303-806D-A72FB5F4225FQ49866596-70D4D555-938D-45DE-8C0A-1FC027D6B4ECQ50863800-7777B7B5-A633-474A-BBF4-DC6D7A7B30B2Q52641579-B7596B89-A423-41C2-8CCF-278989EA4EC5Q55176362-8B562C0E-E69E-406D-8DDF-8A7AF406D0D0Q55239952-95E45E48-744A-40D0-B8C3-C4B6A59DF555Q55438434-9AE02043-A227-43B6-9BAB-BF2AF3413A72
P2860
MicroRNA-7-regulated TLR9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
MicroRNA-7-regulated TLR9 sign ...... gulatory subunit 3/Akt pathway
@ast
MicroRNA-7-regulated TLR9 sign ...... gulatory subunit 3/Akt pathway
@en
MicroRNA-7-regulated TLR9 sign ...... gulatory subunit 3/Akt pathway
@nl
type
label
MicroRNA-7-regulated TLR9 sign ...... gulatory subunit 3/Akt pathway
@ast
MicroRNA-7-regulated TLR9 sign ...... gulatory subunit 3/Akt pathway
@en
MicroRNA-7-regulated TLR9 sign ...... gulatory subunit 3/Akt pathway
@nl
prefLabel
MicroRNA-7-regulated TLR9 sign ...... gulatory subunit 3/Akt pathway
@ast
MicroRNA-7-regulated TLR9 sign ...... gulatory subunit 3/Akt pathway
@en
MicroRNA-7-regulated TLR9 sign ...... gulatory subunit 3/Akt pathway
@nl
P2093
P2860
P356
P1476
MicroRNA-7-regulated TLR9 sign ...... gulatory subunit 3/Akt pathway
@en
P2093
Guangru Fei
Junmin Luo
Qinchuan Li
Zhenke Wen
Zhongmin Liu
P2860
P356
10.1091/MBC.E12-07-0519
P577
2012-11-07T00:00:00Z